Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label multicenter phase 4 study of different starting doses of lurasidone in schizophrenia
CTR20201023Phase 4Active
- Sponsor
- Bushu Pharmaceuticals
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in schizophrenia, sponsored by Bushu Pharmaceuticals. Started Apr 2021; status: active.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20201023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201023.